# CVE-2023-29052: Cross-site scripting in OX App Suite

> Attackers can inject malicious scripts into disclaimer texts, leading to code execution in the victim's browser context.

- **Severity:** Medium 5.4 (`CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** A user has to click or open something
- **Fix available:** No
- **Published:** 8 Jan 2024
- **Updated:** 4 Nov 2025
- **Also known as:** GHSA-xr84-qwr9-vj33

## What is CVE-2023-29052?

CVE-2023-29052 is a medium-severity cross-site scripting vulnerability in Open-Xchange GmbH OX App Suite, published on 8 Jan 2024. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.

### Official description

Users were able to define disclaimer texts for an upsell shop dialog that would contain script code that was not sanitized correctly. Attackers could lure victims to user accounts with malicious script code and make them execute it in the context of a trusted domain. We added sanitization for this content. No publicly available exploits are known.

Weakness: CWE-79 (Improper Neutralization of Input During Web Page Generation)

## Which versions are affected by CVE-2023-29052?

It affects 1 product.


Products: Open-Xchange Ox App Suite.

## How do I fix CVE-2023-29052?

No fix has been published for CVE-2023-29052 yet. Limit exposure of the affected software until one is available.

## Is CVE-2023-29052 being exploited?

There is no known exploitation of CVE-2023-29052 in the wild and no public exploit code.

## Other vulnerabilities in Open-Xchange GmbH OX App Suite

- [CVE-2022-29851](https://insights.sbomify.com/CVE-2022-29851/): Command injection in n/a (critical 9.8)
- [CVE-2022-23100](https://insights.sbomify.com/CVE-2022-23100/): Command injection in n/a (critical 9.8)
- [CVE-2022-24405](https://insights.sbomify.com/CVE-2022-24405/): Command injection in n/a (critical 9.8)
- [CVE-2023-29048](https://insights.sbomify.com/CVE-2023-29048/): Command injection in OX App Suite (high 8.8)
- [CVE-2023-29051](https://insights.sbomify.com/CVE-2023-29051/): Missing authorization in OX App Suite (high 8.1)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2023-29052 and fix it if it is affected.

What it is: CVE-2023-29052 is a medium-severity cross-site scripting vulnerability in Open-Xchange GmbH OX App Suite, published on 8 Jan 2024. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.
Exploitation: There is no known exploitation of CVE-2023-29052 in the wild and no public exploit code.

Affected product: Open-Xchange GmbH OX App Suite. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2023-29052/ (Markdown: https://insights.sbomify.com/CVE-2023-29052/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2023-29052
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2023-29052
- OSV: https://osv.dev/vulnerability/CVE-2023-29052

---
From sbomify Insights: https://insights.sbomify.com/CVE-2023-29052/
Summaries are generated and may contain mistakes; the official description above is the record.